Short answer
Orthofix Medical Inc. (OFIX) filed an 8-K current report with the SEC on June 11, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 5.07 (Submission of Matters to a Vote of Security Holders). Shareholders approved Amendment No. 5 to Orthofix’s stock purchase plan on June 10, 2026.
Orthofix Medical Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Shareholders approved Amendment No. 5 to Orthofix’s stock purchase plan on June 10, 2026
- Share reserve increased by 1,250,000 common shares for employee purchases
- Named executive officers participate, creating potential future equity dilution
- No other plan changes disclosed
Item 5.07 · Submission of Matters to a Vote of Security Holders
- 34,776,676 shares represented, exceeding the 20,192,935-share quorum requirement
- All 10 director nominees elected for one-year terms expiring at the 2027 annual meeting
- Executive compensation approved, with 24,480,474 votes for and 5,577,200 against
- Ernst & Young LLP ratified as fiscal 2026 independent auditor, with 33,262,505 votes for
- Stock Purchase Plan Amendment No. 5 approved, with 29,235,005 votes for
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Orthofix Medical Inc. 8-K filings
Get the next OFIX 8-K as it lands
Follow OFIX for push alerts, or ask the research agent what this filing means.